FDA reverses course and will review Moderna’s mRNA flu shot, company says

By Deidre McPhillips, CNN (CNN) — The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a letter in which it refused to accept the application to review its first mRNA seasonal flu